Saef Izzy

[Prof. Akiko Iwasaki @VirusesImmunity]

Our new preprint by @peowenlu @SaefIzzy @weinerlabhms and colleagues shows that nasal anti-CD3 monoclonal antibody treatment can reduce neuroinflammation in a mouse model of Long COVID, even when administered at 4 weeks after infection 🧠
https://t.co/P8FZA2XA37

[Mass General Brigham Research @MGBResearchNews]

New review highlights how stem cell therapies may boost stroke recovery by teaming up with the immune system to reducing inflammation, protecting brain tissue, and supporting repair.

Read more from @SaefIzzy and colleagues: https://t.co/sPq4vlUynA @BWHNeuroICU @BWHNeurology

[Mass General Brigham Research @MGBResearchNews]

A new study shows people with spinal cord injuries are more likely to develop chronic disorders. The study was published in @JAMANetworkOpen.

Read more: https://t.co/skOfA3RsFj https://t.co/sE43OFIfZB
@SaefIzzy

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

While part of the research team is at AAN, @SaefIzzy is presenting in Vienna at the #ADPD2025 conference on his groundbreaking research. Congrats, Saef! #Neuroscience #braininjury #neuro #mgbneurocritical #neurocritical

[Stepping Strong Center @steppingstrong1]

Congratulations to the 2024 Stepping Strong Breakthrough Award recipient, @SaefIzzy, MD, on his feature in the @BostonGlobe for his development of a nasal therapy that reduces neuroinflammation after a traumatic brain injury (TBI).
https://t.co/L9jhnGlnSr

[Saef Izzy @SaefIzzy]

Honored to speak at the National Academies of Sciences, Engineering, and Medicine workshop on TBI as a Chronic Condition. Excited to discuss long-term impacts and strategies to improve care. Join us!

[Nature Neuroscience @NatureNeuro]

Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury (#TBI), enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent Treg–#microglia crosstalk in mice

@saefizzy @weinerlabhms

https://t.co/oBt2mC3RyD

[Nature Portfolio @NaturePortfolio]

The findings of a study in @NatureNeuro suggest that nasal anti-CD3 represents a promising new therapeutic approach for treating traumatic brain injury and potentially other forms of acute brain injury. https://t.co/4bgoJMVYuG

[Saef Izzy @SaefIzzy]

Nasal Spray Offers Hope for TBI! Our Nature Neuroscience study shows nasal anti-CD3 therapy recruits regulatory immune cells to modulate brain inflammation in mouse models of moderate-to-severe TBI—a promising non-invasive treatment on the horizon! https://t.co/FFij7pQODt

[Brigham and Women's Neurology @BWHNeurology]

Congratulations to @SaefIzzy on his promotion to Associate Professor of Neurology at @harvardmed

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

Dr. Izzy’s @SaefIzzy new study confirms earlier findings published in #JAMA: Traumatic #Brain Injury raises the risk of long-term #cardiovascular and neurological issues, =critical need for early screening and prevention!
https://t.co/DpEQtZ1q74

[Stepping Strong Center @steppingstrong1]

The Stepping Strong Center is pleased to announce the 2024 Stepping Strong Breakthrough Award winner:

Congratulations, Dr. @SaefIzzy!

Dr. Izzy will study a potential treatment for spinal cord injury (SCI) that nasally administers anti-CD3 monoclonal antibody.

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

Huge congratulations to @SaefIzzy for winning 2024 Stepping Strong Breakthrough Award for his research on neuroinflammation treatment targets for #spinalcordinjury #TBI #traumaticbraininjury #neuroscience #NIH🏆 #mgbneurocritical @BrighamWomens @BWHNeurology

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

Throwback to #ncs2024 - second year #mgbneurocritical fellow Sandro’s poster and faculty @SaefIzzy on the ⬆️ incidence of #cardiovascular disease after #TBI in young patients. They followed patients after TBI for 20 years and find a sig ⬆️ in ❤️ risk

[Brian Edlow @ComaRecoveryLab]

Is it appropriate to share clinically relevant research results with active-duty Special Operations Forces?

We explore ethical, legal & operational perspectives, with the goal of empowering Operators who seek information about their brain health.

https://t.co/Pxv6x8kdBz

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

Congrats to faculty @SaefIzzy on an excellent presentation at @neurocriticalcaresociety regarding anti-inflammatory therapies to directly treat edema and secondary injury resulting from #TBI. #ncs2024 #neurocritical #fellowship #neuroicu #neurocriticalcare #MGBneurocritical

[Neurocritical Care Society @neurocritical]

Congratulations to 2024 Fellow of Neurocritical Care Society (FNCS) inductee @SaefIzzy. #NCS2024

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

Congratulations @SaefIzzy after your outstanding talk highlighting breakthroughs in the field of #TBI research. We are excited to see where your work at @BrighamWomens will go in the very near future and bring groundbreaking therapies to the field!! @neurocritical #NCS2024

[Brigham and Women’s Neurocritical Care @BWHNeuroICU]

Neuro ICU Board Review book published online, congratulations! @SaefIzzy

https://t.co/aKG73DxtrD